Nested variant of urothelial carcinoma: A clinicopathologic and immunohistochernical study of 12 cases

被引:70
作者
Lin, O
Cardillo, M
Dalbagni, G
Linkov, I
Hutchinson, B
Reuter, VE
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Urol, New York, NY 10021 USA
[3] Jacobi Med Ctr, Dept Pathol, Bronx, NY USA
关键词
immunohistochemistry; nested; urothelial carcinoma;
D O I
10.1097/01.MP.0000094091.04541.FC
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Nested variant of urothelial carcinoma is characterized by confluent small nests and abortive tubules of mildly atypical neoplastic cells infiltrating the lamina propria and/or muscularis propria of the bladder. Despite its deceptively bland histomorphologic appearance, the lesion is reported to have an aggressive behavior. The collective immunohistochemical expression of suppressor genes, growth factor, and proliferation activity marker has not been previously studied in this disease. Formalin-fixed, paraffin-embedded archival tissues from 12 cases of nested variant of urothelial carcinoma were stained with monoclonal antibodies to p21, p27, p53, EGF-R, and bcl-2, as well as the proliferation marker MIB-1. The area of predominant immunoreactivity was also evaluated. The pattern of immunostaining was compared with the clinical parameters. p21 was positive in 10 of 12 cases and located at the deepest portion of the tumor in 5 of 10 positive cases. Immunoreactivity for p27 was seen in 11 of 12 cases and limited to the superficial portion of the tumor in 9 of 11 positive cases. Only 3 and 2 of 12 cases were positive for p53 and bcl-2, respectively. MIB-1 immunoreactivity ranged from 2 to 35% of the neoplastic cells, with most tumors showing a proliferation index of >15%. Follow-up ranged from 3 to 30 months (mean, 17.6 mo). All patients except one were alive, although three patients developed metastases. Nested variant of urothelial carcinoma is a deceptively benign-appearing neoplasm with potential of deep invasion and metastases. Immunohistochemically, nested variant of urothelial carcinoma shares some features with high-risk conventional urothelial carcinomas, such as loss of p27 expression and high proliferation index. Nevertheless, p53, bcl-2, or EGF-r immunoreactivity is not frequently seen.
引用
收藏
页码:1289 / 1298
页数:10
相关论文
共 34 条
[1]   Prognostic value of Ki-67 for recurrence and progression of superficial bladder cancer [J].
Asakura, T ;
Takano, Y ;
Iki, M ;
Suwa, Y ;
Noguchi, S ;
Kubota, Y ;
Masuda, M .
JOURNAL OF UROLOGY, 1997, 158 (02) :385-388
[2]   Molecular and kinetic features of transitional cell carcinomas of the bladder: biological and clinical implications [J].
Baithun, SI ;
Naase, M ;
Blanes, A ;
Diaz-Cano, SJ .
VIRCHOWS ARCHIV, 2001, 438 (03) :289-297
[3]   Cytologic features of the nested variant of urothelial carcinoma - A study of seven cases [J].
Cardillo, M ;
Reuter, VE ;
Lin, O .
CANCER CYTOPATHOLOGY, 2003, 99 (01) :23-27
[4]   Frequent and heterogenous expression of cyclin-dependent kinase inhibitor WAF1/p21 protein and mRNA in urothelial carcinoma [J].
Clasen, S ;
Schulz, WA ;
Gerharz, CD ;
Grimm, MO ;
Christoph, F ;
Schmitz-Dräger, BJ .
BRITISH JOURNAL OF CANCER, 1998, 77 (04) :515-521
[5]  
CORDONCARDO C, 1995, AM J PATHOL, V147, P545
[6]   Molecular evolution and intratumor heterogeneity by topographic compartments in muscle-invasive transitional cell carcinoma of the urinary bladder [J].
Diaz-Cano, SJ ;
Blanes, A ;
Rubio, J ;
Matilla, A ;
Wolfe, HJ .
LABORATORY INVESTIGATION, 2000, 80 (03) :279-289
[7]  
Drew PA, 1996, MODERN PATHOL, V9, P989
[8]  
Eble JN, 1997, SEMIN DIAGN PATHOL, V14, P98
[9]  
Isimbaldi G, 1999, Pathologica, V91, P192
[10]   Decreasing of p27Kip1 and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer [J].
Kamai, T ;
Takagi, K ;
Asami, H ;
Ito, Y ;
Oshima, H ;
Yoshida, KI .
BRITISH JOURNAL OF CANCER, 2001, 84 (09) :1242-1251